Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PhRMA white paper on ADME pharmacogenomics.

Journal of clinical pharmacology - 1 Jul 2008

Williams J Andrew, Andersson Tommy, Andersson Tommy B, Blanchard Rebecca, Behm Martin Otto, Cohen Nadine, Edeki Timi, Franc Monique, Hillgren Kathleen M, Johnson Keith J, Katz David A, Milton Mark N, Murray Bernard P, Polli Joseph W, Ricci Deb, Shipley Lisa A, Vangala Subrahmanyam, Wrighton Steven A

Abstract excerpt

Pharmacogenomic (PGx) research on the absorption, distribution, metabolism, and excretion (ADME) properties of drugs has begun to have impact for both drug development and utilization. To provide a cross-industry perspective on the utility of ADME PGx, the Pharmaceutical Research and Manufacturers of America (PhRMA) conducted a survey of major pharmaceutical companies on their PGx practices and applications...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arylsulfotransferase
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Industry

Share to Drug Interactions

Share to Glucuronosyltransferase

Share to Multidrug Resistance-Associated Protein 2

Share to Multidrug Resistance-Associated Proteins

Share to Pharmacokinetics

Source

Identifiers

PMID: 18524998
DOI: 10.1177/0091270008319329

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PhRMA white paper on ADME pharmacogenomics.PMID 18524998Read ↗

The Role of ADME Pharmacogenomics in Early Clinical Trials: Perspective of the Industry Pharmacogenomics Working Group (I-PWG)Semantic proximity Read ↗

ADME pharmacogenetics: current practices and future outlook.Semantic proximity Read ↗

Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.Semantic proximity Read ↗

Development of a broad-based ADME panel for use in pharmacogenomic studies.Semantic proximity Read ↗

Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation PerspectivesSemantic proximity Read ↗

Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical PracticeSemantic proximity Read ↗

Dosing recommendations for pharmacogenetic interactions related to drug metabolism.Semantic proximity Read ↗

Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes.Semantic proximity Read ↗

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effectsSemantic proximity Read ↗

Clinically relevant genetic variations in drug metabolizing enzymes.Semantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.